000 | 01157 a2200337 4500 | ||
---|---|---|---|
005 | 20250513071932.0 | ||
264 | 0 | _c19940304 | |
008 | 199403s 0 0 eng d | ||
022 | _a0004-5632 | ||
024 | 7 |
_a10.1177/000456329303000605 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aColbert, D L | |
245 | 0 | 0 |
_aReducing the cost of phenytoin assays with in-house TDx reagents. _h[electronic resource] |
260 |
_bAnnals of clinical biochemistry _cNov 1993 |
||
300 |
_a555-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aCalibration |
650 | 0 | 4 | _aChromatography, Thin Layer |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 |
_aDrug Monitoring _xeconomics |
650 | 0 | 4 | _aFluorescein-5-isothiocyanate |
650 | 0 | 4 |
_aFluorescence Polarization Immunoassay _xeconomics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmune Sera |
650 | 0 | 4 | _aIndicators and Reagents |
650 | 0 | 4 |
_aPhenytoin _xblood |
700 | 1 | _aTurner, G J | |
700 | 1 | _aGooch, J C | |
773 | 0 |
_tAnnals of clinical biochemistry _gvol. 30 ( Pt 6) _gp. 555-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/000456329303000605 _zAvailable from publisher's website |
999 |
_c8304003 _d8304003 |